Integrated approaches to the treatment of mild and moderately severe cognitive impairment in patients in subacute and intermediate periods of traumatic brain injury

Abstract

Brain injury is one of the most common injuries, accounts for about 40 % of all types of injuries and has a tendency to increase. The purpose of the study was to identify Neuromidin efficacy in the treatment of mild and moderately severe cognitive impairment in patients with subacute and intermediate periods of traumatic brain injury. The results of applying integrated approaches with the use of Neuromidin® in the conservative treatment of 60 patients aged 46.00 ± 0.25 years with mild and moderate cognitive impairment in the subacute and intermediate periods of the brain trauma have been analyzed and presented. The dynamics was evaluated according to the Glasgow Outcome Scale, attention — to Schulte tables, anxiety and depression — on the Hospital Anxiety and Depression Scale and rheoencephalography data (rheosystolic index). Positive dynamics in the form of improved attention, reduction of anxiety and depressive disorders, regression of neurological disorders was revealed. Thus, the application of integrated approaches in the conservative treatment of mild and moderate cognitive impairment is an effective method for treating brain injury in the subacute and intermediate periods.